| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
BCL-2 inhibition and AML: can we best Darwin?
|
Michaelis, Laura C.
|
|
|
135 |
11 |
p. 781-782
|
artikel
|
| 2 |
CD45-negative follicular lymphoma
|
Schoonen, Lise
|
|
|
135 |
11 |
p. 879
|
artikel
|
| 3 |
Checkmate for EBV-HLH
|
El-Mallawany, Nader Kim
|
|
|
135 |
11 |
p. 782-784
|
artikel
|
| 4 |
Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis
|
Bezerra, Matheus F.
|
|
|
135 |
11 |
p. 870-875
|
artikel
|
| 5 |
Cooperating mutations: joint forces, novel vulnerabilities
|
Pabst, Caroline
|
|
|
135 |
11 |
p. 785-787
|
artikel
|
| 6 |
Dnmt3a loss and Idh2 neomorphic mutations mutually potentiate malignant hematopoiesis
|
Zhang, Xiaotian
|
|
|
135 |
11 |
p. 845-856
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
135 |
11 |
p. i
|
artikel
|
| 8 |
High efficacy of venetoclax plus obinutuzumab in patients with complex karyotype and chronic lymphocytic leukemia
|
Al-Sawaf, Othman
|
|
|
135 |
11 |
p. 866-870
|
artikel
|
| 9 |
High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo- and autoimmunity
|
Erkers, Tom
|
|
|
135 |
11 |
p. 814-825
|
artikel
|
| 10 |
How I treat adults with advanced acute lymphoblastic leukemia eligible for CD19-targeted immunotherapy
|
Aldoss, Ibrahim
|
|
|
135 |
11 |
p. 804-813
|
artikel
|
| 11 |
IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution
|
Odabashian, Mariette
|
|
|
135 |
11 |
p. 834-844
|
artikel
|
| 12 |
Integrin α9β1: a new target to fight thrombosis
|
Brill, Alexander
|
|
|
135 |
11 |
p. 787-788
|
artikel
|
| 13 |
Long-term outcomes of Sleeping Beauty–generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas
|
Srour, S.A.
|
|
|
135 |
11 |
p. 862-865
|
artikel
|
| 14 |
Microgranular acute promyelocytic leukemia with expression of T-cell markers mimicking mixed-phenotype acute leukemia
|
Liu, Wei
|
|
|
135 |
11 |
p. 880
|
artikel
|
| 15 |
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
|
DiNardo, C.D.
|
|
|
135 |
11 |
p. 791-803
|
artikel
|
| 16 |
Nivolumab treatment of relapsed/refractory Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis in adults
|
Liu, Pengpeng
|
|
|
135 |
11 |
p. 826-833
|
artikel
|
| 17 |
Rossi A, Gauvrit S, Marass M, Pan L, Moens CB, Stainier DYR. Regulation of Vegf signaling by natural and synthetic ligands. Blood. 2016;128(19):2359-2366.
|
|
|
|
135 |
11 |
p. 881
|
artikel
|
| 18 |
Sugar-coated BCR kept during FL clonal evolution
|
Roulland, Sandrine
|
|
|
135 |
11 |
p. 784-785
|
artikel
|
| 19 |
Targeting myeloid-cell specific integrin α9β1 inhibits arterial thrombosis in mice
|
Dhanesha, Nirav
|
|
|
135 |
11 |
p. 857-861
|
artikel
|
| 20 |
Ticagrelor causes false-negative functional tests for heparin-induced thrombocytopenia
|
Eekels, Julia J.M.
|
|
|
135 |
11 |
p. 875-878
|
artikel
|
| 21 |
Venetoclax-obinutuzumab: harnessing complexity
|
Abrisqueta, Pau
|
|
|
135 |
11 |
p. 788-789
|
artikel
|
Tijdschrift beschrijving